New Jersey biologics regulations.

Who may administer PRP, exosomes and stem cells in New Jersey, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in New Jersey?

In New Jersey, licensed medical professionals such as physicians (MD or DO) may administer biologic therapies, including stem cell injections.

Official sources

New Jersey compliance guide.

FDA Compliance

Federal biologics compliance is primarily governed by the FDA’s regulations under Section 361 of the Public Health Service Act, focusing on human cells, tissues, and cellular and tissue-based products (HCT/P). It is critical to review FDA requirements regarding HCT/P to ensure that products meet regulatory standards.

Refer to the FDA's HCT/P guidelines for comprehensive compliance requirements: FDA HCT/P Regulation.

New Jersey State Regulations

New Jersey requires clinics offering biologics to adhere to state-specific health regulations. Providers should regularly check the New Jersey Department of Health for updates on policies and guidelines for cellular therapies and biologics.

For more information, visit the New Jersey Department of Health: New Jersey Department of Health.

Provider Qualifications

In New Jersey, licensed medical professionals such as physicians (MD or DO) may administer biologic therapies, including stem cell injections. Providers must ensure they meet all licensure and training requirements, which can be verified with the New Jersey State Board of Medical Examiners.

To confirm your eligibility and necessary qualifications, visit: New Jersey State Board of Medical Examiners.

Patient Informed Consent

New Jersey clinics must obtain informed consent from patients before providing biologics and stem cell therapies. Consent forms should detail the treatment’s potential risks, benefits, experimental aspects, and lack of FDA approval for some therapies. Clear communication helps patients make informed decisions.

Additional Compliance Areas

Pre-Treatment and Post-Treatment Protocols

Establishing standardized protocols for pre-treatment screening and post-treatment care is essential. This ensures patient safety and aligns with compliance requirements.

Standard Operating Procedures (SOPs)

Well-documented SOPs for all procedures related to biologics are recommended. These should cover preparation, administration, and emergency response protocols, which should be reviewed regularly to remain compliant.

Medical Liability Insurance

New Jersey providers should carry adequate liability insurance to cover risks associated with biologic therapies. Insurance policies should reflect the specific risks of cellular and stem cell treatments.

Marketing Compliance

Marketing for biologics must comply with New Jersey and federal regulations, avoiding unsubstantiated claims and ensuring accuracy. Ads should not imply FDA approval where it does not exist, and any promotional materials should clearly state the experimental nature of therapies.

This guide is a general summary to help clinics understand compliance requirements for biologics in New Jersey. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

New Jersey: common questions.

Who can administer stem cells, PRP and exosomes in New Jersey?
In New Jersey, licensed medical professionals such as physicians (MD or DO) may administer biologic therapies, including stem cell injections. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in New Jersey?
FDA rules are federal, so they apply in New Jersey as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in New Jersey?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in New Jersey?
Start with the live webinar, then a discovery call and live training. After that we verify your New Jersey licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in New Jersey? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.